However, single-cell RNA sequencing datasets reveal that SGLT2 mRNA expression is predominantly restricted to the kidney, even in diabetes (https://humphreyslab.com/SingleCell/displaycharts.php), suggesting the amount of SGLT2 expressed by these cells even in inflammatory conditions is minimal in comparison to that expressed by the proximal tubule. The gene discussed is SLC5A2; the disease is diabetes mellitus.